- Home
- MLP vs MBX Comparison
MLP vs MBX Comparison
Compare MLP & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLP
- MBX
- Stock Information
- Founded
- MLP 1909
- MBX 2018
- Country
- MLP United States
- MBX United States
- Employees
- MLP N/A
- MBX N/A
- Industry
- MLP Real Estate
- MBX
- Sector
- MLP Finance
- MBX
- Exchange
- MLP Nasdaq
- MBX NYSE
- Market Cap
- MLP 295.0M
- MBX 300.5M
- IPO Year
- MLP 1972
- MBX 2024
- Fundamental
- Price
- MLP $15.88
- MBX $12.42
- Analyst Decision
- MLP
- MBX Strong Buy
- Analyst Count
- MLP 0
- MBX 5
- Target Price
- MLP N/A
- MBX $37.40
- AVG Volume (30 Days)
- MLP 20.7K
- MBX 255.6K
- Earning Date
- MLP 05-15-2025
- MBX 05-12-2025
- Dividend Yield
- MLP N/A
- MBX N/A
- EPS Growth
- MLP N/A
- MBX N/A
- EPS
- MLP N/A
- MBX N/A
- Revenue
- MLP $14,886,000.00
- MBX N/A
- Revenue This Year
- MLP N/A
- MBX N/A
- Revenue Next Year
- MLP N/A
- MBX N/A
- P/E Ratio
- MLP N/A
- MBX N/A
- Revenue Growth
- MLP 57.13
- MBX N/A
- 52 Week Low
- MLP $14.05
- MBX $4.81
- 52 Week High
- MLP $26.46
- MBX $27.50
- Technical
- Relative Strength Index (RSI)
- MLP 50.89
- MBX N/A
- Support Level
- MLP $15.60
- MBX N/A
- Resistance Level
- MLP $16.30
- MBX N/A
- Average True Range (ATR)
- MLP 0.75
- MBX 0.00
- MACD
- MLP 0.10
- MBX 0.00
- Stochastic Oscillator
- MLP 44.55
- MBX 0.00
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.